Pagine elettroniche
La prescrizione di farmaci soggetti a Nota nella popolazione pediatrica italiana
THE PRESCRIPTION OF DRUG WITH REIMBURSEMENT LIMITATIONS TO ITALIAN CHILDREN POPULATION
S. Maschi1, A. Clavenna1, E. Rossi2, A. Berti2, M. De Rosa2, M. Bonati1
1Laboratorio per la Salute Materno-Infantile, IRFMN, Milano
2CINECA, Consorzio Interuniversitario, Bologna
Settembre 2005 - pagg. 475 -477
Abstract
The objectives of the study are to evaluate the pattern of
drug prescriptions reimbursed with limitations (AIFA notes) by the
National Health System in the Italian paediatric population. Prescriptions
involving 982,035 children <14 years old, dispensed during
2003 by the retail pharmacies of 24 Italian local health units
participating in the ARNO project, were analysed. A total of
620,239 children (63.2%) received at least one drug prescription;
80,815 received at least one drug associated with an AIFA note.
The note most used, in this prescription sample is note 55; 35,798
children (3.7%) received injectable antibiotics and ceftriaxone is the
most prescribed drug (2.4% of the children). Total expenditure corresponded
to about € 6.4 million: somatropin is the most expensive
drug (36% of the total expenditure). The main limit of the study is represented
by the lack of information about the disease for which
drugs are prescribed. However, from the epidemiologic evaluation
of the drug prescription pattern, it is evident that the notes are insufficient
regulatory tools for rationalising drug use. In order to improve
the appropriateness of drug use, educative and formative interventions
directed to health operators, families and patients are very
important.
Parole chiave
Suggerite dall'AI
Classificazione MeSH
Corrispondenza: mother_child@marionegri.it
